title: Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
abstract: We investigated the influence of the timing of neostigmine administration on recovery from rocuronium or vecuronium neuromuscular blockade. Eighty adults and 80 children were randomized to receive 0.45 mg/kg rocuronium or 0.075 mg/kg vecuronium during propofol/fentanyl/N2O anesthesia. Neuromuscular blockade was monitored by train-of-four (TOF) stimulation and adductor pollicis electromyography. Further randomization was made to control (no neostigmine) or reversal with 0.07 mg/kg neostigmine/0.01 mg/kg glycopyrrolate given 5 min after relaxant, or first twitch (T1) recovery of 1%, 10%, or 25%. Another eight adults and eight children received 1.5 mg/kg succinylcholine. At each age, spontaneous recovery of T1 and TOF was similar after rocuronium and vecuronium administration but was more rapid in children (P < 0.05). Spontaneous recovery to TOF0.7 after rocuronium and vecuronium administration in adults was 45.7 +/- 11.5 min and 52.5 +/- 15.6 min; in children, it was 28.8 +/- 7.8 min and 34.6 +/- 9.0 min. Neostigmine accelerated recovery in all reversal groups (P < 0.05) by approximately 40%, but the times from relaxant administration to TOF0.7 were similar and independent of the timing of neostigmine administration. Recovery to T1 90% after succinylcholine was similar in adults (9.4 +/- 5.0 min) and children (8.4 +/- 1.1 min) and was shorter than recovery to TOF0.7 in any reversal group after rocuronium or vecuronium administration. Recovery from rocuronium and vecuronium blockade after neostigmine administration was more rapid in children than in adults. Return of neuromuscular function after reversal was not influenced by the timing of neostigmine administration. These results suggest that reversal of intense rocuronium or vecuronium neuromuscular blockade need not be delayed until return of appreciable neuromuscular function has been demonstrated.
  
  
  CONCLUSIONS
  These results suggest that reversal of intense rocuronium or vecuronium neuromuscular blockade need not be delayed until return of appreciable neuromuscular function has been demonstrated. Although spontaneous and neostigmine-assisted recovery is more rapid in children than in adults, in neither is return of function as rapid as after succinylcholine administration.
authors.affiliation: Department of Anaesthesia, British Columbia's Children's Hospital, Vancouver, Canada. bevan@interchange.ubc.ca
authors.forename: J C
authors.initials: JC
authors.lastname: Bevan
authors.forename: L
authors.initials: L
authors.lastname: Collins
authors.forename: C
authors.initials: C
authors.lastname: Fowler
authors.forename: R
authors.initials: R
authors.lastname: Kahwaji
authors.forename: H D
authors.initials: HD
authors.lastname: Rosen
authors.forename: M F
authors.initials: MF
authors.lastname: Smith
authors.forename: L D
authors.initials: LD
authors.lastname: de Scheepers
authors.forename: C A
authors.initials: CA
authors.lastname: Stephenson
authors.forename: D R
authors.initials: DR
authors.lastname: Bevan
mesh_terms: D000328:Adult; D000732:Androstanols / Q000037:antagonists & inhibitors; D002648:Child; D002675:Child, Preschool; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D009388:Neostigmine / Q000008:administration & dosage*; D019148:Neuromuscular Blockade; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D000077123:Rocuronium; D013390:Succinylcholine; D013997:Time Factors; D014673:Vecuronium Bromide / Q000037:antagonists & inhibitors
chemical_list: D000732:Androstanols; D002800:Cholinesterase Inhibitors; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine; D014673:Vecuronium Bromide; D013390:Succinylcholine; D000077123:Rocuronium